MODELLING THE LONG-TERM SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) DEL (5Q) TREATED WITH LENALIDOMIDE

被引：0
|
作者：
Benettaib, B. [1 ]
Lee, D. [2 ]
Dhanasiri, S. [3 ]
Brereton, N. [2 ]
机构：
[1] Sarl, Celgene Int, Geneva, Switzerland
[2] BresMed, Sheffield, S Yorkshire, England
[3] Celgene Ltd, Uxbridge, Middx, England
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P740
引用
收藏
页码：310 / 310
页数：1
相关论文
共 50 条
  • [31] Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough?
    Donat Dürr
    Raffaele Daniele Siciliano
    Yvonne Hummel
    Alix O’Meara
    Anita Hirschi
    Roger Burkhard
    Hanspeter Honegger
    Annals of Hematology, 2010, 89 : 105 - 106
  • [32] Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough?
    Duerr, Donat
    Siciliano, Raffaele Daniele
    Hummel, Yvonne
    O'Meara, Alix
    Hirschi, Anita
    Burkhard, Roger
    Honegger, Hanspeter
    ANNALS OF HEMATOLOGY, 2010, 89 (01) : 105 - 106
  • [33] Karyotype does better than FISH for Myelo Dysplastic Syndrome (MDS) with del(5q) treated with lenalidomide
    Eclache, Virginie
    HEMATOLOGIE, 2011, 17 (02): : 110 - 111
  • [34] A PATIENT WITH MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q) AND IRON OVERLOAD TREATED WITH LENALIDOMIDE AND DEFERASIROX: A CASE REPORT
    Guaragna, G.
    Rinaldi, E.
    Girasoli, M.
    Spina, A.
    Mele, G.
    Quarta, G.
    Melpignano, A.
    HAEMATOLOGICA, 2017, 102 : 155 - 155
  • [35] Health and economic impact of the discontinuation of lenalidomide treatment in patients with myelodysplastic syndrome associated with del(5q)
    Alarcon-Payer, C.
    Salazar Bravo, M.
    Jimenez Morales, A.
    Garcia Fumero, R.
    Jurado Chacon, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 380 - 380
  • [36] Validation of the IPSS-R in lenalidomide-treated, lower-risk myelodysplastic syndrome patients with del(5q)
    M A Sekeres
    A S Swern
    P Fenaux
    P L Greenberg
    G F Sanz
    J M Bennett
    F Dreyfus
    A F List
    J S Li
    M M Sugrue
    Blood Cancer Journal, 2014, 4 : e242 - e242
  • [37] Variability in the extent of del(5q) in myelodysplastic syndromes (MDS)
    Zemanova, Zuzana
    Brezinova, Jana
    Svobodova, Karla
    Lhotska, Halka
    Vesela, Denisa
    Belickova, Monika
    Vesela, Jitka
    Izakova, Silvia
    Sarova, Iveta
    Lizcova, Libuse
    Ransdorfova, Sarka
    Pavlistova, Lenka
    Cermak, Jaroslav
    Stopka, Tomas
    Jonasova, Anna
    Michalova, Kyra
    MOLECULAR CYTOGENETICS, 2019, 12
  • [38] Validation of the IPSS-R in lenalidomide-treated, lower-risk myelodysplastic syndrome patients with del(5q)
    Sekeres, M. A.
    Swern, A. S.
    Fenaux, P.
    Greenberg, P. L.
    Sanz, G. F.
    Bennett, J. M.
    Dreyfus, F.
    List, A. F.
    Li, J. S.
    Sugrue, M. M.
    BLOOD CANCER JOURNAL, 2014, 4 : e242 - e242
  • [39] Long-Term Evolution of Somatic Mutations in Patients with Del(5q) MDS Early Treated with Lenalidomide in the Sintra-Rev Clinical Trial: Safe and Effecitive Approach?
    Toribio Castello, Sofia M.
    Lopez-Cadenas, Felix
    Preudhomme, Claude
    Villaverde Ramiro, Angela
    Fenwarth, Laurene
    Lumbreras, Eva
    Gonzalez, Teresa
    Del Rey, Monica
    Xicoy, Blanca
    Renneville, Aline
    Sanchez-Garcia, Joaquin
    Coll, Rosa
    Slama, Bohrane
    Angel Hernandez-Rivas, Jose
    Thepot, Sylvain
    Bernal, Teresa
    Guerci-Bresler, Agnes
    Gotze, Katharina
    Maria Hernandez-Rivas, Jesus
    Fenaux, Pierre
    Del Canizo, Consuelo
    Diez-Campelo, Maria
    BLOOD, 2022, 140 : 9740 - 9743
  • [40] LONG-TERM MUTATIONAL DYNAMICS IN DEL(5Q) MDS PATIENTS EARLY TREATED WTIH LENALIDOMIDE (SINTRAREV CLINICALTRIAL). SAFE AND EFFECITIVE APPROACH REGARDING CLONAL EVOLUTION?
    Toribio Castello, S. M.
    Lopez-Cadenas, F.
    Preudhomme, C.
    Villaverde Ramiro, A.
    Fenwarth, L.
    Lumbreras, E.
    Gonzalez, T.
    Del Rey, M.
    Xicoy, B.
    Renneville, A.
    Sanchez, J.
    Coll, R.
    Slama, B.
    Hernandez Rivas, J. A.
    Thepot, S.
    Bernal, T.
    Guerci-Bresler, A.
    Gotze, K.
    Hernandez Rivas, J. M.
    Fenaux, P.
    Del Canizo, C.
    Campelo, M.
    LEUKEMIA RESEARCH, 2023, 128
12345